The National Forum for Heart Disease & Stroke Prevention submitted comments to the Centers for Medicare & Medicaid Services in support of the proposed Low-Density Lipoprotein Cholesterol Monitoring and Management measure. The comments urge CMS to finalize the measure in Traditional MIPS and include it in the Advancing Care for Heart …
Value & Access Collaborative submits comments on ICER hypertension report
Members of the National Forum for Heart Disease & Stroke Prevention’s Value & Access Collaborative submitted joint comments on ICER’s draft evidence report evaluating baxdrostat and lorundrostat for hypertension. The collaborative called on ICER to revise the report to better reflect: Patient perspectives Contemporary real-world …
How to make shared decisions for better heart health
Knowing your cholesterol can start an important conversation, but the numbers alone do not determine the next step. Cardiovascular risk, treatment benefits and potential side effects, lifestyle changes, and each patient’s priorities all help shape the plan. During National Cholesterol Education Month, the National Forum for Heart Disease & …
National Forum urges CMS to protect access to appropriate kidney care
The National Forum for Heart Disease & Stroke Prevention submitted comments to the Centers for Medicare & Medicaid Services (CMS) regarding updates to the End-Stage Renal Disease Prospective Payment System (PPS). The comments address potential unintended consequences of including phosphate-lowering therapies in the bundled payment …
National Forum Director of Programs Addresses CMS on Medicare Drug Price Negotiation, Patient-Focused Town Hall for Trulicity
On behalf of the National Forum for Heart Disease and Stroke Prevention, Director of Programs Jen Childress presented comments to the Centers for Medicare and Medicaid Services (CMS) during a town hall on Medicare drug price negotiation. Her remarks focused on Trulicity (dulaglutide) and its importance for Medicare beneficiaries living with type …
Medicare Part D 2026: What Caregivers Should Know Before Dec. 7
For caregivers, helping a loved one review their Medicare prescription coverage is one of the most practical ways to support their health. With major changes coming to Medicare Part D in 2026, this year’s open enrollment period — Oct. 15 through Dec. 7 — is especially important. Medicare Part D helps older adults afford the medications they rely …
Medicare Part D Updates for 2026: What You Should Know Before Dec. 7
Each year, Medicare beneficiaries can choose a new prescription drug plan during the open enrollment period. For 2026 coverage, open enrollment runs from Oct. 15 to Dec. 7, and this year brings meaningful updates that may change what you pay for your medications. Medicare Part D provides prescription coverage to more than 54 million …
National Forum Comments on Medicare Drug Price Negotiation Draft Guidance
National Forum urges CMS to ensure that payers do not reduce access to price-negotiated, evidence-based medications that are helping Medicare beneficiaries manage heart disease and stroke risk factors and conditions. Read our comments on Medicare Drug Price Negotiation Draft Guidance. …
National Forum ED Addresses CMS on Medicare Drug Price Negotiation, Patient-Focused Town Hall for Janumet
On behalf of the National Forum for Heart Disease and Stroke Prevention, Executive Director John Clymer presented comments to the Centers for Medicare and Medicaid Services (CMS) during a town hall on Medicare drug price negotiation for Janumet (sitagliptin and metformin). In his remarks, Clymer highlighted Janumet’s once-daily combination …
